Avid Bioservices, Inc.
CDMO · NASDAQ
10/31/2024 | 7/31/2024 | 4/30/2024 | 1/31/2024 | |
|---|---|---|---|---|
| Revenue | $33 | $40 | $43 | $34 |
| % Growth | -16.7% | -6.5% | 27.1% | – |
| Cost of Goods Sold | $36 | $34 | $37 | $31 |
| Gross Profit | -$2 | $6 | $6 | $2 |
| % Margin | -6.1% | 14.2% | 12.8% | 7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $6 | $0 |
| SG&A Expenses | $11 | $8 | $7 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11 | $8 | $7 | $6 |
| Operating Income | -$13 | -$2 | -$1 | -$4 |
| % Margin | -37.7% | -6.1% | -3% | -11.8% |
| Other Income/Exp. Net | -$5 | -$3 | -$4 | -$3 |
| Pre-Tax Income | -$17 | -$6 | -$5 | -$7 |
| Tax Expense | $0 | $0 | $118 | -$1 |
| Net Income | -$17 | -$6 | -$123 | -$6 |
| % Margin | -52% | -13.8% | -286.5% | -17.8% |
| EPS | -0.27 | -0.087 | -1.94 | -0.095 |
| % Growth | -210.3% | 95.5% | -1,944.3% | – |
| EPS Diluted | -0.27 | -0.087 | -1.94 | -0.095 |
| Weighted Avg Shares Out | 64 | 64 | 63 | 63 |
| Weighted Avg Shares Out Dil | 64 | 64 | 63 | 63 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $2 | $2 | $1 |
| Depreciation & Amortization | $4 | $3 | $3 | $3 |
| EBITDA | -$10 | -$0 | -$1 | -$3 |
| % Margin | -30.3% | -0.6% | -1.3% | -9.6% |